These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23426493)

  • 21. Intralesional immunotherapy with tuberculin purified protein derivative for verruca: A study from a teaching hospital in South India.
    Kerure AS; Nath AK; Oudeacoumar P
    Indian J Dermatol Venereol Leprol; 2016; 82(4):420-2. PubMed ID: 27279304
    [No Abstract]   [Full Text] [Related]  

  • 22. Combined bivalent human papillomavirus vaccine and Candida antigen versus Candida antigen alone in the treatment of recalcitrant warts.
    Marei A; Nofal A; Alakad R; Abdel-Hady A
    J Cosmet Dermatol; 2020 Mar; 19(3):758-762. PubMed ID: 31328869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of intralesional wart therapy.
    Muse ME; Stiff KM; Glines KR; Cline A; Feldman SR
    Dermatol Online J; 2020 Mar; 26(3):. PubMed ID: 32609439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intralesional Candida Antigen Immunotherapy for the Treatment of Recalcitrant and Multiple Warts in Children.
    Muñoz Garza FZ; Roé Crespo E; Torres Pradilla M; Aguilera Peirò P; Baltà Cruz S; Hernández Ruiz ME; Baselga Torres E
    Pediatr Dermatol; 2015; 32(6):797-801. PubMed ID: 26584692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunotherapy for recalcitrant warts in children using intralesional mumps or Candida antigens.
    Clifton MM; Johnson SM; Roberson PK; Kincannon J; Horn TD
    Pediatr Dermatol; 2003; 20(3):268-71. PubMed ID: 12787281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intralesional immunotherapy for the management of warts.
    Chandrashekar L
    Indian J Dermatol Venereol Leprol; 2011; 77(3):261-3. PubMed ID: 21508563
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of recalcitrant warts with intralesional measles, mumps, and rubella vaccine: a promising approach.
    Nofal A; Nofal E; Yosef A; Nofal H
    Int J Dermatol; 2015 Jun; 54(6):667-71. PubMed ID: 25070525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intralesional immunotherapy of common warts: successful treatment with mumps, measles and rubella vaccine.
    Nofal A; Nofal E
    J Eur Acad Dermatol Venereol; 2010 Oct; 24(10):1166-70. PubMed ID: 20202055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind, randomized controlled trial to compare the effectiveness and safety of purified protein derivative of tuberculin antigen with
    Chandra S; Sil A; Datta A; Pal S; Das NK
    Indian J Dermatol Venereol Leprol; 2019; 85(4):355-366. PubMed ID: 31172979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diphencyprone immunotherapy for viral warts in immunosuppressed patients.
    Audrain H; Siddiqui H; Buckley DA
    Br J Dermatol; 2013 May; 168(5):1138-9. PubMed ID: 23210741
    [No Abstract]   [Full Text] [Related]  

  • 31. Intralesional immunotherapy for genital warts.
    King M; Johnson SM; Horn TD
    Arch Dermatol; 2005 Dec; 141(12):1606-7. PubMed ID: 16365274
    [No Abstract]   [Full Text] [Related]  

  • 32. Intralesional Versus Intramuscular Hepatitis B Virus Vaccine in the Treatment of Multiple Common Warts.
    Nofal A; Elaraby A; Elkholy BM
    Dermatol Surg; 2022 Nov; 48(11):1178-1184. PubMed ID: 36165681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alternating intralesional purified protein derivative and Candida antigen versus either agent alone in the treatment of multiple common warts.
    Nofal A; Yehia E; Khater E; Bessar H
    J Am Acad Dermatol; 2020 Jul; 83(1):208-210. PubMed ID: 32006600
    [No Abstract]   [Full Text] [Related]  

  • 34. Intralesional bleomycin in the treatment of cutaneous warts: a randomized clinical trial comparing it with cryotherapy.
    Dhar SB; Rashid MM; Islam A; Bhuiyan M
    Indian J Dermatol Venereol Leprol; 2009; 75(3):262-7. PubMed ID: 19439878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intralesional Vitamin D3 in Recalcitrant Palmoplantar and Periungual Warts: A Prospective, Observational Study.
    Priya A; Adil M; Amin SS; Mohtashim M; Bansal R; Alam M
    Acta Dermatovenerol Croat; 2019 Dec; 27(4):215-224. PubMed ID: 31969233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intralesional Candida antigen for common warts in people with HIV.
    Wong A; Crawford RI
    J Cutan Med Surg; 2013; 17(5):313-5. PubMed ID: 24067850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intralesional vitamin D3 versus intralesional purified protein derivative in treatment of multiple warts: A comparative clinical and immunological study.
    Abou-Taleb DAE; Abou-Taleb HA; El-Badawy O; Ahmed AO; Thabiet Hassan AE; Awad SM
    Dermatol Ther; 2019 Sep; 32(5):e13034. PubMed ID: 31355514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New proposal for the treatment of viral warts with intralesional injection of 5-aminolevulinic acid photodynamic therapy.
    Kim JE; Kim SJ; Hwang JI; Lee KJ; Park HJ; Cho BK
    J Dermatolog Treat; 2012 Jun; 23(3):192-5. PubMed ID: 21756150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minocycline successfully treats exaggerated granulomatous hypersensitivity reaction to Mw immunotherapy.
    Vinay K; Narang T; Saikia UN; Kumaran MS; Dogra S
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27891740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Verrucous vulva": Meeting therapeutic challenges in massive condyloma acuminata with intralesional immunotherapy.
    Singh S
    Indian J Dermatol Venereol Leprol; 2020; 86(4):456-458. PubMed ID: 32415053
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.